| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/04/2007 | CA2409999C Optical polymer mixtures for gastric retentive tablets |
| 09/04/2007 | CA2405429C Minoxidil-containing preparation |
| 09/04/2007 | CA2374688C Composite laminate and process for producing it |
| 09/04/2007 | CA2291622C Reversible geling co-polymer and method of making |
| 09/04/2007 | CA2219698C Sustained-release preparation |
| 09/04/2007 | CA2125643C Pharmaceutical composition having analgesic activity |
| 09/04/2007 | CA2116238C Oral 1 .alpha.-hydroxyprevitamin d |
| 08/30/2007 | WO2007098466A2 Segmented degradable polymers and conjugates made therefrom |
| 08/30/2007 | WO2007098128A2 Phenylephrine-containing liquid formulations |
| 08/30/2007 | WO2007098033A2 Feedback prodrug |
| 08/30/2007 | WO2007097412A1 Oil-in-water emulsion composition containing licorice-derived polyphenol |
| 08/30/2007 | WO2007097386A1 Stabilized pharmaceutical composition |
| 08/30/2007 | WO2007097357A1 Volatile sulfide production inhibitor and method for inhibiting the production of volatile sulfide using the inhibitor |
| 08/30/2007 | WO2007097333A1 Granules, tablets and method of producing the same |
| 08/30/2007 | WO2007097325A1 Pharmaceutical composition comprising oseltamivir phosphate |
| 08/30/2007 | WO2007097315A1 Enteric gelatinous nutrient and method of preparing the same |
| 08/30/2007 | WO2007096900A1 Stable pharmaceutical composition of taxanes |
| 08/30/2007 | WO2007096388A1 Polypeptides, pharmaceutical compositions and methods for the prevention and the therapeutic treatment of inflammatory disorders |
| 08/30/2007 | WO2007096382A2 Method for production of a transformed cell |
| 08/30/2007 | WO2007096160A1 Aerosol and use thereof |
| 08/30/2007 | WO2007095749A1 Cytotoxicity mediation of cells evidencing surface expression of trop-2 |
| 08/30/2007 | WO2007095748A1 Cancerous disease modifying antibody 141205-05 |
| 08/30/2007 | WO2007095746A1 Cancerous disease modifying antibodies |
| 08/30/2007 | WO2007095745A1 Cancerous disease modifying antibody 141205-02 |
| 08/30/2007 | WO2007095729A1 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 08/30/2007 | WO2007095722A1 Doxorubicin formulations for anti-cancer use |
| 08/30/2007 | WO2007079915A3 Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect |
| 08/30/2007 | WO2007050643A3 Compositions and their uses for gene therapy of bone conditions |
| 08/30/2007 | WO2007036802A3 Sublingual dosage form comrising vitamin d analogue, in particular calcitriol |
| 08/30/2007 | WO2007036792A3 Kit for parenteral administration of medicaments |
| 08/30/2007 | WO2006117567A3 Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase |
| 08/30/2007 | WO2000001393A8 OLIGONUCLEOTIDE INHIBITORS OF bcl-xL |
| 08/30/2007 | US20070203264 Poly (ethylene glycol) derivatives with proximal reactive groups |
| 08/30/2007 | US20070203237 Method for preventing or treating obesity |
| 08/30/2007 | US20070203166 Administering non-gas containing nanoparticles comprising a mixture of select lipids capable of being internalized within a targeted tissue or cell sufficient to achieve a desired effect and anticancer agent |
| 08/30/2007 | US20070203165 Compounds and methods for lowering the abuse potential and extending the duration of action of a drug |
| 08/30/2007 | US20070203069 Grf-containing lyophilized pharmaceutical compositions |
| 08/30/2007 | US20070203058 Novel Glp-1 Derivatives |
| 08/30/2007 | US20070203057 Compounds and methods for modulating adhesion molecule function |
| 08/30/2007 | US20070202600 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 08/30/2007 | US20070202598 New transfection reagents |
| 08/30/2007 | US20070202577 Method For The Production Of Hyperbranched Polysaccharide Fractions |
| 08/30/2007 | US20070202524 Targeted Vectors |
| 08/30/2007 | US20070202178 Drug delivery matrices to enhance wound healing |
| 08/30/2007 | US20070202171 Method Of Producing A Pharmaceutical Composition |
| 08/30/2007 | US20070202168 Composition comprises sustained-release fine particles and manufacturing method thereof |
| 08/30/2007 | US20070202160 Solid-state form of celecoxib having enhanced bioavailability |
| 08/30/2007 | US20070202153 Liquid Concentrated Formula |
| 08/30/2007 | US20070202152 Method For Encapsulation Of Orally Ingested Materials To Alter The Site Of Digestion, Site Of Action, Or Stability |
| 08/30/2007 | US20070202103 Compounds For Targeting |
| 08/30/2007 | US20070202099 Antibody Drug |
| 08/30/2007 | US20070202090 Water Soluble Form Of Coenzyme Q10 In The Form Of An Inclusion Complex With Beta-Cyclodextrin, Process Of Preparing, And Use Thereof |
| 08/30/2007 | US20070202045 Serum albumin binding peptides for tumor targeting |
| 08/30/2007 | US20070202040 Supplying radionuclide to blood clot; ultrasonic imaging; diagnosis, therapy |
| 08/30/2007 | DE10045374B4 Verfahren zur Herstellung von Mikroteilchen mit verzögerter Freisetzung Process for the preparation of sustained release microparticles |
| 08/30/2007 | CA2643603A1 Cytotoxicity mediation of cells evidencing surface expression of trop-2 |
| 08/30/2007 | CA2643561A1 Cancerous disease modifying antibody 141205-05 |
| 08/30/2007 | CA2643274A1 Oil-in-water emulsion composition containing licorice-derived polyphenol |
| 08/30/2007 | CA2643144A1 Cancerous disease modifying antibody 141205-04 |
| 08/30/2007 | CA2643063A1 Cancerous disease modifying antibody 141205-02 |
| 08/30/2007 | CA2643059A1 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 08/30/2007 | CA2643054A1 Granules, tablets and method of producing the same |
| 08/30/2007 | CA2642952A1 Pharmaceutical composition comprising oseltamivir phosphate |
| 08/30/2007 | CA2642905A1 Segmented degradable polymers and conjugates made therefrom |
| 08/30/2007 | CA2642726A1 Stable vitamin c compositions |
| 08/30/2007 | CA2642048A1 Phenylephrine containing liquid formulations |
| 08/30/2007 | CA2640997A1 Doxorubicin formulations for anti-cancer use |
| 08/30/2007 | CA2640331A1 Stabilized pharmaceutical composition |
| 08/29/2007 | EP1826216A1 Glp-1 derivatives |
| 08/29/2007 | EP1825866A1 Solid preparation |
| 08/29/2007 | EP1825865A2 Stabilised preparations of serine endopeptidases, their production and application |
| 08/29/2007 | EP1825849A1 Transdermal therapeutic system comprising fentanyl |
| 08/29/2007 | EP1824979A2 Methods, products and uses involving platelets and/or the vasculature |
| 08/29/2007 | EP1824531A1 Biomaterials carrying cyclodextrines having improved absorption properties and used for the progressive and delayed release of therapeutic molecules |
| 08/29/2007 | EP1824521A2 Ultrasound contrast agents for molecular imaging |
| 08/29/2007 | EP1824516A2 Glycan analysis using deuterated glucose |
| 08/29/2007 | EP1824498A2 Methods and compositions for treating cellular proliferative diseases |
| 08/29/2007 | EP1824494A1 Topical drug delivery system |
| 08/29/2007 | EP1824485A1 Pharmaceutical formulation for increasing solubility of 10-hydroxycamptothecin compounds in non-aqueous polar solvents |
| 08/29/2007 | EP1824474A1 Anthelmintic composition |
| 08/29/2007 | EP1824460A2 A stabilized polymeric delivery system |
| 08/29/2007 | EP1824452A1 Aqueous dispersions of a mixture of only slightly water soluble or water insoluble active substances and a single-celled protein material |
| 08/29/2007 | EP1465933B1 Polymer conjugates |
| 08/29/2007 | EP1450847A4 Apo2 ligand/trail formulations |
| 08/29/2007 | EP1443912B1 Compositions having a combination of immediate release and controlled release characteristics |
| 08/29/2007 | EP1441700B1 Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
| 08/29/2007 | EP1425019B1 Pharmaceutical composition comprising an androgen |
| 08/29/2007 | EP1423126B1 Treatment of hyperproliferative conditions of body surfaces |
| 08/29/2007 | EP1377180B1 Microcapsules |
| 08/29/2007 | EP1341525B1 Granulation process using halogenated hydrocarbon |
| 08/29/2007 | EP1306083A4 Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion |
| 08/29/2007 | EP1140024B1 Particles for oral delivery of peptides and proteins |
| 08/29/2007 | EP0983086B1 pH-SENSITIVE LIPOSOMES AND OTHER TYPES OF ENCAPSULATED VACCINES CONTAINING IMMUNOMODULATORS, AND METHODS FOR MAKING AND USING SAME |
| 08/29/2007 | EP0915684B1 Material for buffered resorbable internal fixation devices and method for making same |
| 08/29/2007 | CN101027087A Use of targeted oxidative therapeutic formulation in treatment of diabetes and obesity |
| 08/29/2007 | CN101027086A Use of targeted oxidative therapeutic formulation in bone regeneration |
| 08/29/2007 | CN101027077A Ejection liquid, ejection device, ejection cartridge, and method of making droplets from liquid |
| 08/29/2007 | CN101027076A Ejection liquid, ejection method, method for forming liquid droplets, liquid ejection cartridge and ejection apparatus |
| 08/29/2007 | CN101027073A Natriuretic compounds, conjugates, and uses thereof |
| 08/29/2007 | CN101027067A Antitumor composition |